{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:19:15Z","timestamp":1782191955005,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.semarthrit.2024.152522","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T08:04:24Z","timestamp":1720944264000},"page":"152522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-0735","authenticated-orcid":false,"given":"Ke Li","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Elizabeth","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sapsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Liston","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152522_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12948-018-0084-9","article-title":"Bench to bedside review of myositis autoantibodies","volume":"16","author":"Palterer","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-023-01045-w","article-title":"International guideline for idiopathic inflammatory myopathy-associated cancer screening: an international myositis assessment and clinical studies group (IMACS) initiative","author":"Oldroyd","year":"20231912805","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0003","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pathol.2021.03.010","article-title":"HMGCR autoantibody testing: two tiers required","volume":"54","author":"Chow","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0004","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200 and 100 kDa proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0006","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0007","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0008","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0009","first-page":"1","article-title":"Genetic basis of limb-girdle muscular dystrophies: the 2014 update","volume":"33","author":"Nigro","year":"2014","journal-title":"Acta Myol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217831120","article-title":"Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone","volume":"120","author":"Yogev","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0011","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/BOR.0000000000000832","article-title":"Anti-HMGCR myopathy: clinical and histopathological features, and prognosis","volume":"33","author":"Kurashige","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0012","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0014","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/rai2.12059","article-title":"Phenotypical statin-associated immune-mediated necrotizing myositis with histological features of inclusion body myositis","volume":"3","author":"Daver","year":"2023","journal-title":"Rheumatol Autoimmun"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0015","first-page":"637","article-title":"FRI0395 Incidence of myositis-specific autoantibody (MSA) specificities in sera referred to New Zealand (NZ) medical laboratories","volume":"76","author":"O'Donnell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0016","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/imj.13023","article-title":"HMGCR-associated myositis: a New Zealand case series and estimate of incidence","volume":"46","author":"Kennedy","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0017","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.pathol.2018.04.001","article-title":"Response to: new immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis","volume":"50","author":"Keating","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0018","unstructured":"Ethnic profile, Environmental Health Intelligence New Zealand [accessed 11 November 2023]. Available from: https:\/\/www.ehinz.ac.nz\/indicators\/population-vulnerability\/ethnic-profile\/."},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152522_bib0019","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.pathol.2017.04.013","article-title":"New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis","volume":"49","author":"Droney","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141616","article-title":"Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"10","author":"Ge","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0021","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/imj.16004","article-title":"Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy","volume":"53","author":"Tan","year":"2023","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0022","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0023","doi-asserted-by":"crossref","first-page":"adv00415","DOI":"10.2340\/00015555-3645","article-title":"Unusual skin involvement in statin-induced anti-HMGCR immune-mediated necrotizing myopathy","volume":"101","author":"Scard","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0025","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00415-022-11459-3","article-title":"Inclusion body myositis: from genetics to clinical trials","volume":"270","author":"Nagy","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.01.006","article-title":"Frailty and sarcopenia: the potential role of an aged immune system","volume":"36","author":"Wilson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotizing myopathy: a multi-centre South Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0028","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0029","doi-asserted-by":"crossref","first-page":"320","DOI":"10.55563\/clinexprheumatol\/2ao5ze","article-title":"Treatment and outcomes in anti-HMG-CoA reductase-associated immune-necrotizing myopathy. Comparative analysis of a single-centre cohort and published data","volume":"40","author":"Rademacher","year":"2022","journal-title":"Clin and Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1034\/j.1399-0039.2002.590506.x","article-title":"HLA-DRB and HLA-DQB1 polymorphisms in Pacific Islands populations","volume":"59","author":"Velickovic","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.semarthrit.2024.152522_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1464-5491.2001.00435.x","article-title":"Polynesians: prone to obesity and type 2 diabetes mellitus but not hyperinsulinemia","volume":"18","author":"Simmons","year":"2001","journal-title":"Diabet Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:14:38Z","timestamp":1726618478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"alternative-id":["S0049017224001628"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152522","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152522"}}